Chase Heaton, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat (NCT03823131) | Chase Heaton, MD | 2019-05-02 |
Track Chase Heaton, MD automatically
Every clearance here is in the API, with alerts when new ones post.